Table 1

Quality assessment—PEDro score

		Pedro score											Total score (items 2–11)
Condition	First author (year)	1	2	3	4	5	6	7	8	9	10	11	Total score (items 2–11)
Cancer	Galantino (2003)32	✓	✓										1
	Mustian (200441 200618 2008)19 Sprod (2012)49	✓	✓	✓	✓						✓	✓	5
	Robins (2013)39		✓	✓	✓						✓	✓	5
	Rausch (2007)53	✓	✓		✓					✓	✓	✓	5
	Campo (2013)45	✓	✓	✓	✓						✓	✓	5
OA	Adler (2007)54	✓	✓	✓						✓		✓	4
	Brismée (2007)36	✓	✓		✓						✓	✓	4
	Fransen (2007)33	✓	✓	✓	✓				✓	✓	✓	✓	7
	Hartman (2000)31	✓	✓		✓				✓		✓	✓	5
	Lee (2009)24	✓	✓	✓	✓				✓	✓	✓	✓	7
	Song (200323 2007)50	✓	✓	✓	✓						✓	✓	5
	Song (2010)38	✓	✓		✓						✓	✓	4
	Tsai (2013)37		✓		✓					✓	✓	✓	5
	Wang (2009)44	✓	✓	✓	✓				✓	✓	✓	✓	7
HF	Barrow (2007)22		✓		✓						✓	✓	4
	Yeh (200452 2008a21 2008b)51	✓	✓	✓	✓				✓	✓	✓	✓	7
	Yeh (2011)43	✓	✓	✓	✓				✓	✓	✓	✓	7
	Yeh (2013)55	✓	✓	✓					✓	✓	✓	✓	6
	Caminiti (2011)58	✓	✓		✓				✓		✓	✓	5
COPD	Chan (201035 201134 2013a46 2013b)47	✓	✓	✓	✓					✓	✓	✓	6
	Leung (2013)56	✓	✓	✓					✓	✓	✓	✓	6
	Yeh (2010)42	✓	✓	✓						✓	✓	✓	5
	Niu (2014)40	✓	✓	✓	✓			✓	✓		✓	✓	7
	Ng (2014)57	✓	✓	✓						✓	✓	✓	5
Subtotals of each item		21	24	16	18	0	0	1	10	13	22	23	Median 5

1: Eligibility criteria speciﬁed; 2: random allocation; 3: concealed allocation; 4: groups similar at baseline; 5: respondents blinding; 6: therapists blinding; 7: assessors blinding; 8: less than 15% dropouts; 9: intention-to-treat analysis; 10: between-group statistical comparisons; 11: point measures and measures of variability data.
COPD, chronic obstructive pulmonary disease; HF, heart failure; OA, osteoarthritis; PEDro, Physiotherapy Evidence-Based Database.